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Abstract: Lifestyle medicine 
interventions are typically intensive by 
design. This study explored the optimal 
“dosage” of a well-known lifestyle 
medicine intervention—the Complete 
Health Improvement Program (CHIP). 
A total of 2383 individuals (mean 
age = 61.0 ± 9.2 years; 34% males) 
participated in either an 8-session 
(N = 448) or 16-session (N = 1935) 
version of the CHIP intervention 
conducted over 4 weeks in community 
settings throughout North America. 
Both the 8- and 16-session groups 
experienced significant improvements 
in all the chronic disease risk factors 
measured. There was no difference 
between the changes experienced by 
the 8- and 16-session groups in lipid 
profile, fasting plasma glucose, or 
systolic blood pressure. The 8-session 
group experienced a significantly 
greater reduction in body mass (0.3 
percentage points or 0.8 lbs, P < .01), 
but the 16-session group recorded 
a significantly greater reduction in 
diastolic blood pressure (2.8 percentage 
points or 2.2 mm Hg, P < .01). There 
was no clear difference between the 
outcomes achieved in 4 weeks by 
the 8- and 16-session versions of the 
CHIP lifestyle medicine intervention. 
This study suggests that the short-term 
outcomes achieved by a 16-session 
CHIP intervention can be achieved in 
half the number of sessions, which has 
implications from a resourcing and 
cost-effectiveness perspective.
Keywords: lifestyle intervention; 
chronic disease; disease management; 
health promotion; risk factors
Chronic diseases are responsible for 7 out of 10 deaths in the United States and account for 
approximately 75% of national health 
care expenditure.1 Indeed, there is a 
desperate need for effective 
countermeasures to address this 
pandemic of chronic disease.2
It is well established that chronic 
diseases are lifestyle related,3,4 with over 
80% of myocardial infarctions, over 90% 
of type 2 diabetes mellitus, and 
approximately one third of cancers 
preventable through healthy lifestyle 
choices.4 More encouragingly, an 
accumulating body of evidence 
demonstrates that chronic diseases are 
responsive to therapeutic lifestyle 
intervention,5-8 also referred to as 
“lifestyle medicine” interventions.
Lifestyle medicine interventions are 
typically intense with regard to the 
number of sessions individuals 
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participate in, especially in the first 3 to 
4 weeks of the program. For example, 
the Ornish Program,9 which has 
demonstrated atherosclerotic plaque 
regression in a randomized-controlled 
trial,6 involves three 4-hour sessions in 
the first week and two 4-hour sessions 
for the next 8 weeks. The pioneering 
residential lifestyle medicine 
intervention at the Pritikin Longevity 
Center,10 the outcomes of which have 
been published in over 100 scholarly 
publications,11 involves a 3-week live-in 
experience with daily sessions. The 
community-based Complete Health 
Improvement Program (CHIP),12 now 
used in numerous countries, has 
historically involved 16 group sessions 
within the first 4 weeks.
These lifestyle medicine interventions 
are strategically designed to be intense in 
the initial stages to facilitate rapid results 
and subsequently increase participant’s 
self-efficacy and motivation for behavior 
change.12 However, the intense nature of 
the programs can require high levels of 
resourcing and associated costs. For 
lifestyle medicine interventions to be 
optimally designed to balance efficacy 
and cost-effectiveness, a greater 
understanding of the “dose response” is 
required. To date, little attention has 
been given to defining the optimal 
dosage of lifestyle interventions with 
most programs arbitrarily selecting the 
number, duration, and density of 
sessions in the program. A more 
structured and systematic study of the 
responsiveness to programs of various 
intensities is therefore needed.
The present study examined the 
short-term effects on participant 
outcomes of halving the number of 
sessions of the CHIP lifestyle medicine 
intervention. The CHIP intervention was 
selected for this study as it has been 
identified by the American College of 
Lifestyle Medicine as achieving some of 
the most clinically significant short-term 
reductions in chronic disease risk factors 
in the literature.12 Historically, the 
intervention has involved 16 group 
sessions over a 4-week period. The 
present study compared the short-term 
(4-week) outcomes of the traditional 
16-session program to a modified 
8-session version.
Methods
The study compared the changes in 
selected chronic disease risk factors of 
participants in 2 variants of the CHIP 
lifestyle intervention conducted over 4 
weeks: a standard 16-session version and 
a modified 8-session version. The study 
was approved by the Avondale College 
Human Research Ethics Committee (No. 
20:10:07).
Subjects
A total of 2383 self-selected subjects 
participated in the study (mean age = 
61.0 ± 9.2 years; 809 males/1574 
females). The 16-session group involved 
data collected from 1935 individuals who 
participated in 1 of 101 CHIP 
interventions conducted throughout 
North America (mean group size = 19.4 
± 17.5). The 8-session group consisted of 
448 individuals who participated in 1 of 
21 interventions (mean group size = 21.8 
± 8.4), called “Healthy Beginnings,” 
conducted in 6 communities in Indiana.
Description of the 
Interventions
The CHIP lifestyle intervention has 
been described in detail previously in 
this journal.12 CHIP is a primarily 
nutrition-centered program that 
encourages participants to move toward 
a whole-food, plant-based eating pattern. 
In the first 5 days of the program, 
participants are encouraged to consume 
only fruits, vegetables, whole grains, 
legumes, and water as a Jump Start 
experience. Participants are also 
encouraged to be physically active, with 
the goal being to achieve 10 000 steps 
per day, and attention is given to stress 
management and increasing emotional 
well-being. Each session is approximately 
1.5 hours in duration, with approximately 
half this time consisting of group 
discussion and activities and the other 
half viewing a prerecorded expert 
lecture.
The program is informed by the theory 
of planned behaviour13 and aims to 
change participants attitudes toward 
healthful living through education, 
achieved by viewing the expert lectures 
in each session; foster supportive social 
norms through group activities; and 
build perceived control by providing 
participants with a measureable 
experience of improving their health 
status through biometric assessments 
conducted at the beginning and end of 
the program.
The core themes, messages, and calls 
to action in the 8-session “Healthy 
Beginnings” intervention were identical 
to the CHIP intervention described 
above. However, while the sessions in 
the 8- and 16-session interventions were 
of similar duration, the 8-session version 
utilized shorter video presentations and 
more group activities. There were other 
variant features of the 2 interventions, 
but these variations also existed within 
the 2 cohorts. Variant features included 
the geographical location of the 
programs and the experience of the 
facilitators who delivered them. All 
facilitators were volunteers certified by 
the Lifestyle Medicine Institute (who 
administers the interventions); however, 
the professional background of the 
facilitators varied widely. In addition, 
some programs served the participants 
food samples or full meals during the 
sessions.
Measurements
At program entry and after 4 weeks, 
the participants’ body mass and blood 
pressure (BP) were measured. In 
addition, blood samples were collected 
by trained phlebotomists and analyzed at 
local pathology laboratories for total 
cholesterol (TC), low-density lipoprotein 
(LDL), high-density lipoprotein (HDL), 
triglycerides (TG), and fasting plasma 
glucose (FPG).
Statistical Analysis
The data were analyzed using IBM 
SPSS Statistics (version 22) and are 
expressed as means ± standard 
deviations. The data were initially 
cleaned and outliers removed. Chi-square 
was used to assess differences in the 
gender balance of the groups. 
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Independent samples t tests were used 
to assess differences between the groups 
in age and baseline biometrics (Table 1).
The primary interest of the study was 
the effect of group (8 vs 16 sessions) on 
the pre to post changes in the 
biometrics. Initially, independent 
samples t tests were used to assess 
differences between the groups in the 
biometric changes with Cohen’s d 
calculated to express effect size (Table 2). 
As age, gender, and baseline biometric 
level can influence changes in the 
respective biometrics,14-16 a series of 
regression analyses were then 
conducted with change in the 
respective biometric being the 
dependent variable in each analysis and 
age, gender, the baseline value of the 
biometric and group entered into the 
models (Table 3). The standardized 
coefficients and R2 for the models are 
also reported.
Results
The participants in the 8- and 
16-session groups were similar in age 
(61.1 ± 9.0 vs 61.0 ± 9.2 years, 
respectively, P = .81); however, the 
16-session group had a higher 
percentage of males (35% vs 29%, 
respectively, P = .01).
Table 1 shows the baseline biometrics 
of the participants in the 8- and 
16-session groups. The 8-session group 
had a higher mean body mass and FPG, 
but lower LDL and HDL levels.
Comparisons between the 8- and 
16-session groups in the pre- to 
postintervention biometric changes are 
presented in Table 2. The only significant 
differences between the groups were the 
changes in body mass and diastolic BP, 
although in both instances the effect size 
was small. The 8-session group 
experienced a significantly greater 
reduction in body mass, amounting to 
0.3 percentage points or 0.8 lbs greater 
reduction than the 16-session group. 
Conversely, the 16-session group 
recorded a 2.2 mm Hg greater decrease 
in diastolic BP, equating to 2.8 
percentage points. Controlling for age, 
gender, and the baseline level of the 
respective biometric, the 8-session group 
still achieved greater weight loss and the 
16-session group greater reductions in 
diastolic BP (Table 3). Noteworthy, the 
regression models explained between 
19% and 55% of the variance in the 
biometric changes with the baseline level 
of the biometric being the most 
important contributor in all models. As 
reported previously,14-16 both age and 
gender predicted changes in several of 
the biometrics with the younger males in 
the cohort generally achieving better 
outcomes.
Discussion
The results of the present study 
indicated no clear difference between 
the outcomes achieved in 4 weeks by the 
8- and 16-session versions of the CHIP 
lifestyle medicine intervention.
An obvious question that arises from 
this study is how low could the number 
of sessions be reduced to without 
compromising the efficacy of the 
intervention? From a cost-effectiveness 
perspective, the optimal number of 
sessions is the minimum number 
required to still achieve maximum 
benefits. Further study is therefore 
warranted to consider the comparative 
effectiveness of a 4- or 6-session CHIP 
intervention conducted over 4 weeks. 
However, it should be noted that further 
Table 1.
Baseline Measures for the 8-Session and 16-Session Groups.
8-Session Group
16-Session 
Group
Mean 
Difference % Difference P Value ES  Mean SD Mean SD
Mass (lb) 196.1 42.5 190.2 45.9 5.9 3.0% <.001 0.13
Systolic BP (mm Hg) 135.2 18.1 134.8 18.7 0.4 0% .721 0.02
Diastolic BP (mm Hg) 79.0 11.0 79.8 10.6 −0.8 1.0% .146 0.07
TC (mg/dL) 193.0 43.2 193.5 42.1 −0.5 0.3% .806 0.01
LDL (mg/dL) 116.3 36.0 121.2 38.4 −4.9 4.2% .014 0.13
HDL (mg/dL) 47.8 14.6 50.2 15.9 −2.4 5.0% <.01 0.16
Triglycerides (mg/dL) 145.6 88.7 143.1 88.6 2.5 1.7% .589 0.03
FPG (mg/dL) 106.5 31.7 102.5 29.5 4.0 3.8% .011 0.13
Abbreviations: SD, standard deviation; ES, effect size (Cohen’s d); BP, blood pressure; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density 
lipoprotein; FPG, fasting plasma glucose.
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reducing the number of sessions would 
considerably compromise the 
comprehensive nature of the content 
presented in the program, resulting in it 
being difficult to achieve the learning 
and experiences currently offered in the 
program. In addition, as explained in the 
Methods section, one of the behavior 
change strategies of the CHIP 
intervention is to foster group support, 
which is a common theme in lifestyle 
medicine interventions,6,8,12 and this 
would be more difficult to achieve in 
fewer sessions.
This study contributes to a needed 
understanding of how the number of 
sessions in the early phase of a lifestyle 
medicine intervention (ie, the density of 
Table 2.
Comparison of the Mean Changes in Selected Risk Factors From Baseline to Postintervention for the 8-Session and 16-Session 
Groups.
8-Session Group Change 16-Session Group Change
Mean 
Difference
% Point 
Difference P Value ES  Mean SD % Mean SD %
Mass (lb) −6.9 4.9 −3.5% −6.0 4.9 −3.2% 0.9 0.3% <.001 0.18
Systolic BP (mm Hg) −7.0 16.2 −5.2% −7.7 15.5 −5.7% 0.7 0.5% .437 0.04
Diastolic BP (mm Hg) −2.4 9.9 −3.0% −4.6 10.0 −5.8% −2.2 2.8% <.001 0.22
TC (mg/dL) −21.1 26.0 −10.9% −23.4 27.0 −12.1% 2.3 −1.2% .133 0.09
LDL (mg/dL) −15.5 23.1 −13.3% −16.5 23.0 −13.6% 1.0 −0.3% .459 0.04
HDL (mg/dL) −4.3 7.5 −9.0% −4.8 7.4 −9.6% −0.5 −0.6% .294 0.07
Trig (mg/dL) −11.2 56.4 −7.7% −14.1 55.0 −9.9% 2.9 1.4% .321 0.05
FPG (mg/dL) −8.1 24.0 −7.6% −7.2 19.3 −7.0% 0.9 −0.6% .418 0.04
Abbreviations: SD, standard deviation; ES, effect size (Cohen’s d); BP, blood pressure; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density 
lipoprotein; FPG, fasting plasma glucose.
Table 3.
Regression Analyses Showing the Influence of Age, Gender, Baseline Level of the Respective Biometric, and Group (8-Session or 
16-Session) on Pre to Post Biometric Changes.
Δ Body 
Mass
Δ Systolic 
BP
Δ Diastolic 
BP Δ TC Δ LDL Δ HDL
Δ 
Triglycerides Δ FPG
R2 0.24 0.33 0.32 0.28 0.23 0.17 0.38 0.55
Age −0.09,  
P < .001
−0.15,  
P < .001
0.08,  
P < .001
−0.06,  
P = .001
−0.05,  
P = .014
−0.06,  
P = .005
−0.03,  
P = .113
−0.01,  
P = .505
Gender −0.05,  
P = .017
0.01,  
P = .686
−0.02,  
P = .367
−0.19,  
P < .001
−0.12,  
P < .001
−0.06,  
P = .004
−0.05,  
P = .001
−0.03,  
P = .058
Baseline of 
biometric
0.44,  
P < .001
0.60,  
P < .001
0.57,  
P < .001
0.54,  
P < .001
0.47,  
P < .001
0.43,  
P < .001
0.61, 
P < .001
0.74,  
P < .001
Group −0.05,  
P = .009
0.01,  
P = .476
0.06, P < 
.001
0.02,  
P = .303
−0.01,  
P = .605
−0.01,  
P = .563
0.03,  
P = .146
0.02,  
P = .130
Abbreviations: Δ, change; BP, blood pressure; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FPG, fasting plasma 
glucose.
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sessions) influences its initial outcomes. 
However, the intensiveness, or “dosage,” 
of a lifestyle medicine intervention may 
also be affected by several other factors, 
including the duration of the sessions, 
extent of lifestyle modifications 
prescribed by the intervention, and the 
group size.
In this study, the duration of the 
sessions in both 8- and 16-session 
programs were similar (1.5-2 hours), but 
other well-documented lifestyle medicine 
interventions such as the Ornish9 and 
Esselstyn8 programs involve sessions of 
longer duration. The Ornish program 
involves 4-hour sessions, and Esselstyn 
requires participants to participate in a 
5-hour initial consult. Further research is 
warranted to better understand the 
influence of session duration on 
participant outcomes.
With regard to the magnitude of 
lifestyle change prescribed, lifestyle 
medicine interventions tend to be 
nutrition-centered and prescribe a 
whole-food, plant-based eating 
pattern.6,8,12 This eating pattern is more 
rigorous than that recommended by the 
Dietary Guidelines for Americans,17 
which is commonly used as a guiding 
principle for more conservative lifestyle 
interventions that do not target disease 
regression. However, there are varying 
levels of dietary “dosage” among the 
well-documented lifestyle medicine 
interventions. Esselstyn18 mandates a 
very low-fat vegetarian diet 
(approximately 7% fat), achieved by 
avoiding even plant foods with higher fat 
content such as nuts and avocados. The 
Ornish program, while still low fat 
compared to National Guidelines (ie, 
20% to 35% of total calories),19 allows the 
inclusion of low-fat dairy. Ornish has 
shown that there is a dose-response to 
lifestyle medicine intervention, with 
greater changes resulting in greater 
improvements.6 However, research is 
required to better understand the 
dose-response to lifestyle medicine 
interventions in order to optimize not 
only the efficacy but also the 
acceptability, palatability, and ultimately 
uptake of these interventions by 
individuals who could benefit from them.
Finally, studies are required to elucidate 
the optimal number of participants in 
lifestyle medicine interventions. While 
one-on-one coaching has been utilized 
in programs like the Diabetes Prevention 
Program, the economic viability and 
hence scalability of this approach has 
been questioned and instead group-
based programs have been advocated.20 
Interestingly, weight loss studies have 
indicated that even individuals who 
prefer one-on-one coaching still achieve 
better weight loss when assigned to a 
group intervention.21 Hence, group-
based interventions might be preferable 
from both cost and clinical perspectives. 
Notwithstanding, the educational 
literature shows that excessively large 
groups/class sizes may not be ideal.22 
The optimal group size for lifestyle 
medicine interventions, which may vary 
in different contexts, needs to be 
investigated.
It is acknowledged that the findings of 
the study are limited to short-term 
responsiveness and cannot be 
extrapolated to longer term outcomes. As 
this study did not follow-up the 
participants beyond the 4-week 
intervention, it is not possible to 
determine whether the 16-session 
version more effectively cemented 
behavior change resulting in greater 
long-term compliance to the lifestyle 
practices promoted in the program and 
less recidivism. A long-term study of the 
CHIP intervention (ie, 3-5 year 
follow-up) indicated that participants 
who attended monthly “alumni” group 
support meetings conducted after the 
4-week intervention were more likely to 
comply to the lifestyle recommendations 
of the program and experience greater 
long-term improvements in chronic 
disease risk factors.23 This is consistent 
with findings of studies of the Diabetes 
Prevention Program that found that each 
additional session an individual 
participated in over a 6- to 12-month 
period equated to a 0.26 percentage 
point decrease in body weight.20 These 
findings, combined with those of the 
present study, suggest that 8 sessions are 
probably enough in the first 4 weeks of 
a lifestyle medicine intervention to 
achieve significant reductions in chronic 
disease risk factors, comparable to that 
achieved by 16 sessions, but it is 
beneficial for follow-up sessions to be 
offered after this initial period to 
optimize longer term outcomes.
Conclusion
The findings of the study indicate that 
an 8-session version of the CHIP lifestyle 
medicine intervention achieves 
comparable reductions in chronic disease 
risk factors over 4 weeks to that achieved 
by the 16-session version of the program. 
This finding provides perspective on the 
necessary intensiveness of lifestyle 
medicine interventions, which is 
important in order to design programs 
for optimal clinical and cost 
effectiveness.
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